Lithium suppliers

Melting point:

180 °C (lit.)

Boiling point:

1342 °C (lit.)

Density 

0.534 g/mL at 25 °C (lit.)

vapor pressure 

1 hPa (723 °C)

storage temp. 

water-free area

solubility 

reacts with H2O

form 

wire

Specific Gravity

0.534

color 

Silvery

Odor

Odorless

PH Range

>12

PH

5.0 (20°C in H2O)

Flame Color

Pink-red or magenta

Resistivity

9.446 μΩ-cm, 20°C

Water Solubility 

REACTS

Sensitive 

air sensitive, moisture sensitive

Merck 

13,5542

Exposure limits

ACGIH: TWA 2 ppm; STEL 4 ppm
OSHA: TWA 2 ppm(5 mg/m3)
NIOSH: IDLH 25 ppm; TWA 2 ppm(5 mg/m3); STEL 4 ppm(10 mg/m3)

Stability:

Stable, but reacts violently with water.

LogP

-0.77 at 25℃

CAS DataBase Reference

7439-93-2(CAS DataBase Reference)

NIST Chemistry Reference

Lithium(7439-93-2)

EPA Substance Registry System

Lithium (7439-93-2)

Symbol(GHS) 

GHS02,GHS05

Signal word 

Danger

Hazard statements 

H260-H314

Precautionary statements 

P223-P231+P232-P280-P305+P351+P338-P370+P378-P422

Hazard Codes 

Xi,C,F

Risk Statements 

36/38-34-14/15-23

Safety Statements 

8-43-45-43C-36/37/39-26

RIDADR 

UN 3264 8/PG 3

WGK Germany 

2

RTECS 

OJ5540000

F 

10

Autoignition Temperature

179oC

TSCA 

Yes

HS Code 

2805 19 90

HazardClass 

4.3

PackingGroup 

I

Hazardous Substances Data

7439-93-2(Hazardous Substances Data)

Toxicity

An element used clinically as one of its salts. It is effective against both mania and depression. Despite its effectiveness, there are no clear mechanisms that have been directly related to its therapeutic effectiveness although its inhibition of the formation of inositol from inositol phosphate is thought to be important. At therapeutic concentrations, lithium causes almost no discernible psychotropic effects in healthy humans. The major complaints when the serum concentrations of the drug are carefully monitored include slight muscular weakness, thirst, and excessive urination. The major difficulty with lithium is that a fairly high concentration of the ion is needed in the blood (0.5_x0002_1.0 mmol/L) for maintenance, higher for acute mania. Toxic symptoms (which can involve many physiological symptoms) may occur, however, at doses of 1.5 mmol/L or higher. This low therapeutic index is indicative of the need for regular monitoring of lithium concentrations in the serum.